Northeast Pharmaceutical Group Co Ltd Asset Resilience Ratio

Latest as of June 2026: 1.64%

Northeast Pharmaceutical Group Co Ltd asset resilience ratio. Northeast Pharmaceutical Group Co Ltd (000597) has an Asset Resilience Ratio of 1.64% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See operational self-sufficiency of Northeast Pharmaceutical Group Co Ltd to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥222.89 Million

≈ $32.62 Million USD Cash + Short-term Investments

Total Assets

CN¥13.58 Billion

≈ $1.99 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Northeast Pharmaceutical Group Co Ltd (1993–2025)

Asset resilience ratio of Northeast Pharmaceutical Group Co Ltd from 1993 to 2025. This chart shows how Northeast Pharmaceutical Group Co Ltd's Asset Resilience Ratio has changed over time. Read 000597 current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Northeast Pharmaceutical Group Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of Northeast Pharmaceutical Group Co Ltd.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥222.89 Million	1.64%
Total Liquid Assets	CN¥222.89 Million	1.64%

Asset Resilience Insights

Limited Liquidity: Northeast Pharmaceutical Group Co Ltd maintains only 1.64% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Northeast Pharmaceutical Group Co Ltd Industry Peers by Asset Resilience Ratio

Compare Northeast Pharmaceutical Group Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Sandoz Group AG SW:SDZ	Drug Manufacturers - Specialty & Generic	7.89%
H Lundbeck A/S CO:HLUN-B	Drug Manufacturers - Specialty & Generic	-0.56%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	47.16%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Viyash Scientific Limited NSE:SEQUENT	Drug Manufacturers - Specialty & Generic	0.08%
Anhui Fengyuan Pharmaceutical Co Ltd SHE:000153	Drug Manufacturers - Specialty & Generic	1.81%

Northeast Pharmaceutical Group Co Ltd Asset Resilience Ratio by Year (1993–2025)

Northeast Pharmaceutical Group Co Ltd asset resilience ratio by year from 1993 to 2025. The table below shows the annual Asset Resilience Ratio data for Northeast Pharmaceutical Group Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.00%	CN¥350.62K ≈ $51.31K	CN¥12.89 Billion ≈ $1.89 Billion	+0.02pp
2018-12-31	-0.01%	CN¥-1.64 Million ≈ $-239.76K	CN¥11.72 Billion ≈ $1.71 Billion	+0.00pp
2017-12-31	-0.02%	CN¥-1.76 Million ≈ $-256.97K	CN¥10.59 Billion ≈ $1.55 Billion	-0.01pp
2016-12-31	-0.01%	CN¥-891.00K ≈ $-130.38K	CN¥9.79 Billion ≈ $1.43 Billion	+0.01pp
2015-12-31	-0.02%	CN¥-1.85 Million ≈ $-271.27K	CN¥8.69 Billion ≈ $1.27 Billion	+0.01pp
2014-12-31	-0.04%	CN¥-3.07 Million ≈ $-448.62K	CN¥8.57 Billion ≈ $1.25 Billion	+0.02pp
2013-12-31	-0.06%	CN¥-4.23 Million ≈ $-618.37K	CN¥7.55 Billion ≈ $1.11 Billion	+0.03pp
2012-12-31	-0.08%	CN¥-4.99 Million ≈ $-729.79K	CN¥5.99 Billion ≈ $877.00 Million	+0.01pp
2011-12-31	-0.10%	CN¥-5.76 Million ≈ $-842.35K	CN¥5.87 Billion ≈ $859.33 Million	+0.87pp
2009-12-31	-0.97%	CN¥-58.99 Million ≈ $-8.63 Million	CN¥6.08 Billion ≈ $889.54 Million	-1.10pp
2005-12-31	0.13%	CN¥3.06 Million ≈ $447.63K	CN¥2.30 Billion ≈ $336.25 Million	0.00pp
2004-12-31	0.14%	CN¥3.29 Million ≈ $482.02K	CN¥2.43 Billion ≈ $356.22 Million	+0.12pp
2003-12-31	0.02%	CN¥477.00K ≈ $69.80K	CN¥2.52 Billion ≈ $369.01 Million	-0.01pp
2002-12-31	0.03%	CN¥777.00K ≈ $113.70K	CN¥2.68 Billion ≈ $392.31 Million	-0.01pp
2001-12-31	0.04%	CN¥966.00K ≈ $141.36K	CN¥2.76 Billion ≈ $403.29 Million	-2.48pp
1999-12-31	2.52%	CN¥65.50 Million ≈ $9.58 Million	CN¥2.60 Billion ≈ $380.66 Million	-0.01pp
1998-12-31	2.53%	CN¥65.50 Million ≈ $9.58 Million	CN¥2.59 Billion ≈ $379.02 Million	-0.50pp
1997-12-31	3.02%	CN¥65.50 Million ≈ $9.58 Million	CN¥2.17 Billion ≈ $316.94 Million	-0.38pp
1996-12-31	3.41%	CN¥105.50 Million ≈ $15.44 Million	CN¥3.10 Billion ≈ $453.22 Million	+3.16pp
1993-12-31	0.24%	CN¥3.66 Million ≈ $535.13K	CN¥1.50 Billion ≈ $220.01 Million	--

pp = percentage points

About Northeast Pharmaceutical Group Co Ltd

SHE:000597 China Drug Manufacturers - Specialty & Generic

Market Cap

$935.44 Million

CN¥6.39 Billion CNY

Market Cap Rank

#8893 Global

#2101 in China

Share Price

CN¥4.48

Change (1 day)

+1.59%

52-Week Range

CN¥4.20 - CN¥5.86

All Time High

CN¥133.00